1. Home
  2. HUMAW vs FENG Comparison

HUMAW vs FENG Comparison

Compare HUMAW & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMAW
  • FENG
  • Stock Information
  • Founded
  • HUMAW 2004
  • FENG 1998
  • Country
  • HUMAW United States
  • FENG China
  • Employees
  • HUMAW 220
  • FENG N/A
  • Industry
  • HUMAW Biotechnology: Pharmaceutical Preparations
  • FENG Broadcasting
  • Sector
  • HUMAW Health Care
  • FENG Industrials
  • Exchange
  • HUMAW Nasdaq
  • FENG Nasdaq
  • Market Cap
  • HUMAW N/A
  • FENG N/A
  • IPO Year
  • HUMAW N/A
  • FENG 2011
  • Fundamental
  • Price
  • HUMAW $0.60
  • FENG $2.08
  • Analyst Decision
  • HUMAW
  • FENG
  • Analyst Count
  • HUMAW 0
  • FENG 0
  • Target Price
  • HUMAW N/A
  • FENG N/A
  • AVG Volume (30 Days)
  • HUMAW 14.2K
  • FENG 10.0K
  • Earning Date
  • HUMAW 03-21-2025
  • FENG 05-14-2025
  • Dividend Yield
  • HUMAW N/A
  • FENG N/A
  • EPS Growth
  • HUMAW N/A
  • FENG N/A
  • EPS
  • HUMAW N/A
  • FENG N/A
  • Revenue
  • HUMAW N/A
  • FENG $97,280,369.00
  • Revenue This Year
  • HUMAW N/A
  • FENG N/A
  • Revenue Next Year
  • HUMAW N/A
  • FENG N/A
  • P/E Ratio
  • HUMAW N/A
  • FENG N/A
  • Revenue Growth
  • HUMAW N/A
  • FENG 1.04
  • 52 Week Low
  • HUMAW $1.18
  • FENG $1.28
  • 52 Week High
  • HUMAW $1.34
  • FENG $4.15
  • Technical
  • Relative Strength Index (RSI)
  • HUMAW N/A
  • FENG 47.55
  • Support Level
  • HUMAW N/A
  • FENG $2.00
  • Resistance Level
  • HUMAW N/A
  • FENG $2.38
  • Average True Range (ATR)
  • HUMAW 0.00
  • FENG 0.15
  • MACD
  • HUMAW 0.00
  • FENG -0.03
  • Stochastic Oscillator
  • HUMAW 0.00
  • FENG 16.67

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: